News
The section includes updates and press releases from hepCoalition and partner organizations. Includes highlights of upcoming events, actions, and important meetings.
Calendar
Curated list of key international conferences and meetings related to hepatitis C, substance user health, and harm reduction.
Partner News
The section includes updates from partner organizations on related advocacy efforts.
From Principle to Practice: Involving Communities in Research Design for Effective Hepatitis C Prevention
Unitaid’s funding to support the integration of hepatitis C testing and treatment in harm reduction services, while trialing the use of two underused products to prevent infection. More
ECDC: High Burden of Hepatitis B and C Persists in the EU/EEA
Recent ECDC data show that despite progress in prevention and control efforts, hepatitis B and C continue to pose significant public health challenges in the European Union and European Economic Area. More
Press Releases
Press releases from hepCoalition and partner organizations.
Treatment for Hepatitis C: The Patent System is Standing in the Way of Access to Medicine
Following the appeal filed by AIDES, Médecins du Monde and Médecins sans Frontières, the European Patent Office has decided to uphold the patent of sofosbuvir, hindering the launch of an affordable generic version of the drug in Europe. More
TAG Welcomes Addition of Ravidasvir to WHO Essential Medicines List for Treatment of Hepatitis C Virus
Ravidasvir is the first HCV cure to be developed through South-South collaboration and with funding and clinical support from non-profit organizations. It is now recommended for use in combination with sofosbuvir as an alternative pangenotypic DAA. More